AI Technology Democratising Access to Clinical Trials. In the third episode of Narratives of Purpose's special series on Advancing Women's Health, host Claire Murigande explores the intersection of AI and women's health with Danielle Ralic, CEO and founder of Ancora.ai. Ancora, an AI-powered clinical trial matching platform, aims to democratise access to trials and accelerate research. Danielle and Claire discuss the healthcare system's shortcomings in serving women, particularly in clinical trials. The conversation also touches on the broader implications of gender inclusivity in AI and the startup ecosystem, emphasising the need for more support for women-led ventures in healthcare innovation.Be sure to visit our podcast website for the full episode transcript.References for content mentioned in this episode:Gender bias in medicine articleGender funding gap data by UBS RELEVANT LINKS:More about Ancora at this websiteFollow Ancora: LinkedIn | YouTube | Instagram | FacebookConnect with our guest, Danielle Ralic: LINKEDIN Read our Women's Health articles: blog postsFollow our host Dr. Claire Murigande: WEBSITE | LINKEDINFollow us: LinkedIn | Instagram Connect with us: narrativespodcast@gmail.com | subscribe to our news Tell us what you think: write a review  This special series on Advancing Women's Health with Female Founders is supported by TechFace, Lean In Switzerland, and Ladies Drive.CHAPTERS:00:00 Episode Introduction00:42 The Critical Role of Women in Clinical Trials01:32 Introducing the Host and the Podcast02:26 The Genesis of Ancora.ai04:16 The Power of AI in Democratising Clinical Trials06:23 Ancora's Dual Approach for Patients and Physicians07:55 The Impact and Evolution of Ancora11:08 Advocating for Women's Health and Inclusion in AI13:23 The Future of Women in Tech and Healthcare Innovation14:49 Closing Remarks and Further Resources